GTAEXS617

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase I/IIBreast cancer Lung cancer Ovarian cancer Pancreatic cancer Head and neck cancer Triple negative (TNBC)HER2 positive Hormone receptor positive (HR+)

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655ClinicalTrials.gov ↗

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants with advanced solid tumors.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.